Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

From rare disorders of immunity to common determinants of infection: Following the mechanistic thread
Jean‐Laurent Casanova, Laurent Abel
Cell (2022) Vol. 185, Iss. 17, pp. 3086-3103
Open Access | Times Cited: 101

Showing 1-25 of 101 citing articles:

Autoantibodies against type I IFNs in patients with critical influenza pneumonia
Qian Zhang, Andrés Pizzorno, Lisa Miorin, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 11
Open Access | Times Cited: 74
Human IRF1 governs macrophagic IFN-γ immunity to mycobacteria
Jérémie Rosain, Anna‐Lena Neehus, Jérémy Manry, et al.
Cell (2023) Vol. 186, Iss. 3, pp. 621-645.e33
Open Access | Times Cited: 59
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
Daniela Matuozzo, Estelle Talouarn, Astrid Marchal, et al.
Genome Medicine (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 54
Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in ∼40% of patients
Adrian Gervais, Francesca Rovida, Maria Antonietta Avanzini, et al.
The Journal of Experimental Medicine (2023) Vol. 220, Iss. 9
Open Access | Times Cited: 54
Early cellular mechanisms of type I interferon-driven susceptibility to tuberculosis
Dmitri I. Kotov, Ophelia V. Lee, Stefan A. Fattinger, et al.
Cell (2023) Vol. 186, Iss. 25, pp. 5536-5553.e22
Open Access | Times Cited: 47
Human IL-23 is essential for IFN-γ–dependent immunity to mycobacteria
Quentin Philippot, Masato Ogishi, Jonathan Bohlen, et al.
Science Immunology (2023) Vol. 8, Iss. 80
Open Access | Times Cited: 45
Unlocking life-threatening COVID-19 through two types of inborn errors of type I IFNs
Jean‐Laurent Casanova, Mark S. Anderson
Journal of Clinical Investigation (2023) Vol. 133, Iss. 3
Open Access | Times Cited: 40
Interferon- γ and infectious diseases: Lessons and prospects
Jean‐Laurent Casanova, John D. MacMicking, Carl Nathan
Science (2024) Vol. 384, Iss. 6693
Closed Access | Times Cited: 37
Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children
Paul Bastard, Adrian Gervais, Maki Taniguchi, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 2
Open Access | Times Cited: 22
Human autoantibodies neutralizing type I IFNs: From 1981 to 2023
Paul Bastard, Adrian Gervais, Tom Le Voyer, et al.
Immunological Reviews (2024) Vol. 322, Iss. 1, pp. 98-112
Open Access | Times Cited: 20
The ouroboros of autoimmunity
Jean‐Laurent Casanova, Jessica N. Peel, Jean Donadieu, et al.
Nature Immunology (2024) Vol. 25, Iss. 5, pp. 743-754
Closed Access | Times Cited: 16
Impaired IL-23–dependent induction of IFN-γ underlies mycobacterial disease in patients with inherited TYK2 deficiency
Masato Ogishi, Andrés A. Arias, Rui Yang, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 10
Open Access | Times Cited: 41
Humans with inherited MyD88 and IRAK-4 deficiencies are predisposed to hypoxemic COVID-19 pneumonia
Ana García‐García, Rebeca Pérez de Diego, Carlos Flores, et al.
The Journal of Experimental Medicine (2023) Vol. 220, Iss. 5
Open Access | Times Cited: 34
Dissecting human population variation in single-cell responses to SARS-CoV-2
Yann Aquino, Aurélie Bisiaux, Zhi Li, et al.
Nature (2023) Vol. 621, Iss. 7977, pp. 120-128
Open Access | Times Cited: 34
The ins and outs of innate and adaptive type 2 immunity
Ari B. Molofsky, Richard M. Locksley
Immunity (2023) Vol. 56, Iss. 4, pp. 704-722
Open Access | Times Cited: 31
Interfering with Interferons: A Critical Mechanism for Critical COVID-19 Pneumonia
Helen C. Su, Huie Jing, Yu Zhang, et al.
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 561-585
Open Access | Times Cited: 31
Developing a multiepitope vaccine for the prevention of SARS-CoV-2 and monkeypox virus co-infection: A reverse vaccinology analysis
Fan Jiang, Yinping Liu, Yong Xue, et al.
International Immunopharmacology (2023) Vol. 115, pp. 109728-109728
Open Access | Times Cited: 26
New genetic and epigenetic insights into the chemokine system: the latest discoveries aiding progression toward precision medicine
Hanli Xu, Shuye Lin, Ziyun Zhou, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 7, pp. 739-776
Open Access | Times Cited: 25
A half-century of research on tuberculosis: Successes and challenges
Barry R. Bloom
The Journal of Experimental Medicine (2023) Vol. 220, Iss. 9
Open Access | Times Cited: 25
Human inherited complete STAT2 deficiency underlies inflammatory viral diseases
Giorgia Bucciol, Leen Moens, Masato Ogishi, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 12
Open Access | Times Cited: 23
Autoantibodies Neutralizing Type I IFNs in the Bronchoalveolar Lavage of at Least 10% of Patients During Life-Threatening COVID-19 Pneumonia
Quentin Philippot, Arnaud Fekkar, Adrian Gervais, et al.
Journal of Clinical Immunology (2023) Vol. 43, Iss. 6, pp. 1093-1103
Open Access | Times Cited: 23
Type I interferons induce an epigenetically distinct memory B cell subset in chronic viral infection
Lucy Cooper, Hui Xu, Jack Polmear, et al.
Immunity (2024) Vol. 57, Iss. 5, pp. 1037-1055.e6
Closed Access | Times Cited: 10
The Microbe, the Infection Enigma, and the Host
Jean‐Laurent Casanova, Laurent Abel
Annual Review of Microbiology (2024) Vol. 78, Iss. 1, pp. 103-124
Closed Access | Times Cited: 8
Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination
Aurélien Sokal, Paul Bastard, Pascal Chappert, et al.
The Journal of Experimental Medicine (2022) Vol. 220, Iss. 1
Open Access | Times Cited: 31
Impact of SARS-CoV-2 infection and COVID-19 on patients with inborn errors of immunity
Stuart G. Tangye, Laurent Abel, Salah Al-Muhsen, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 151, Iss. 4, pp. 818-831
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top